Tanaka C, Yoshimoto K, Yamada S, Nishioka H, Ii S, Moritani M, Yamaoka T, Itakura M
Otsuka Department of Clinical and Molecular Nutrition, The University of Tokushima School of Medicine, Tokushima-City, Japan.
J Clin Endocrinol Metab. 1998 Mar;83(3):960-5. doi: 10.1210/jcem.83.3.4653.
Germ-line mutations of the MEN1 gene were analyzed in five cases of familial and four cases of sporadic multiple endocrine neoplasia type 1 (MEN-1), six cases in three independent pedigrees of familial pituitary adenoma without MEN-1, and three cases of familial isolated primary hyperparathyroidism (FIHP) in Japanese. Eight different types of germ-line mutations in all nine cases of MEN-1 were distributed in exons 2, 3, 7, and 10 and intron 7 of the MEN1 gene. Loss of heterozygosity (LOH) on 11q13 was detected in all nine tumors of these cases with microsatellite analysis. No germ-line mutation of the MEN1 gene was detected in three pedigrees of familial pituitary adenoma and three cases of FIHP. LOH on 11q13 was detected in two cases in one pedigree of familial pituitary adenoma, and one of them showed a heterozygous somatic mutation of the MEN1 gene. No LOH on 11q13 was detected in three cases of FIHP. Based on these, we conclude that the loss of function of menin is etiological for familial or sporadic MEN-1, but not for FIHP or most familial pituitary adenoma without MEN-1.
在5例家族性和4例散发性1型多发性内分泌肿瘤(MEN-1)、6例来自3个无MEN-1的家族性垂体腺瘤独立家系以及3例日本家族性孤立性原发性甲状旁腺功能亢进症(FIHP)患者中分析了MEN1基因的种系突变。9例MEN-1患者中的8种不同类型种系突变分布在MEN1基因的第2、3、7和10外显子以及第7内含子。通过微卫星分析在这些病例的所有9个肿瘤中均检测到11q13的杂合性缺失(LOH)。在3个家族性垂体腺瘤家系和3例FIHP患者中未检测到MEN1基因的种系突变。在1个家族性垂体腺瘤家系的2例患者中检测到11q13的LOH,其中1例显示MEN1基因杂合性体细胞突变。3例FIHP患者中未检测到11q13的LOH。基于这些结果,我们得出结论,menin功能丧失是家族性或散发性MEN-1的病因,但不是FIHP或大多数无MEN-1的家族性垂体腺瘤的病因。